NASDAQ

Fintel reports that on May 10, 2023, B of A Securities maintained coverage of Exact Sciences (NASDAQ:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 9.61% Upside As of April 24, 2023, the average one-year price target for Exact Sciences is 77.82. The forecasts range from a low of 55.55…

Fintel reports that on May 10, 2023, Credit Suisse maintained coverage of Exact Sciences (NASDAQ:EXAS) with a Neutral recommendation. Analyst Price Forecast Suggests 9.61% Upside As of April 24, 2023, the average one-year price target for Exact Sciences is 77.82. The forecasts range from a low of 55.55 to a…

Fintel reports that on May 10, 2023, Craig-Hallum upgraded their outlook for Exact Sciences (NASDAQ:EXAS) from Hold to Buy . Analyst Price Forecast Suggests 9.61% Upside As of April 24, 2023, the average one-year price target for Exact Sciences is 77.82. The forecasts range from a low of 55.55 to…

KUALA LUMPUR, Malaysia, May 10, 2023 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) announced that it has signed an Initial Public Offering (“IPO”) advisory mandate with Agroz Group Sdn Bhd (“Agroz”). This IPO advisory mandate entails a USD2 million advisory fees and also a success…

Fintel reports that on May 9, 2023, Needham maintained coverage of EverQuote Inc - (NASDAQ:EVER) with a Buy recommendation. Analyst Price Forecast Suggests 179.92% Upside As of April 24, 2023, the average one-year price target for EverQuote Inc - is 18.62. The forecasts range from a low of 8.08 to…

TOKYO, May 09, 2023 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced today that it has entered into a definitive agreement with Aviat Networks, Inc. (Nasdaq: AVNW), the leading expert in wireless transport and access solutions, to integrate its Wireless Transport Business with Aviat's in an asset purchase transaction…

KELOWNA, BC / ACCESSWIRE / May 8, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the pricing of its public offering of 2,106,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant…

Now at the beginning of the month of May, we see fewer executives being recruited this week in the forex, crypto and fintech industries. Let’s review the executives that have taken on new roles and challenges in our executive moves roundup of the week. HFM Hires Markets.com’s Yaqub Tale as…

Stock markets suffered through a rough year in 2022. Major indices like the S&P 500 (SPY) and NASDAQ 100 were down double digits across the board. Yet this simple strategy showed a solid double-digit gain by taking profitable positions in both good AND bad stocks. This type of balanced approach…

Fintel reports that on May 5, 2023, Cantor Fitzgerald maintained coverage of Celldex Therapeutics (NASDAQ:CLDX) with a Overweight recommendation. Analyst Price Forecast Suggests 103.82% Upside As of April 24, 2023, the average one-year price target for Celldex Therapeutics is 67.83. The forecasts range from a low of 55.55 to a…